Literature DB >> 14651169

Ovarian endometrioma associated with very high serum CA-125 levels.

Chii-Shinn Shiau1, Ming-Yang Chang, Chi-Hsin Chiang, Ching-Chang Hsieh, T'sang-Tang Hsieh.   

Abstract

CA-125 is a 220-kD cell surface glycoprotein present in over 80% of non-mucinous epithelial ovarian carcinomas and it occurs in the serum of healthy males and females at low concentrations (< 35 U/mL). Serum CA-125 concentration may also be moderately elevated in several benign conditions, such as pelvic inflammatory disease, uterine fibroids, pregnancy, spontaneous abortion with chromosomal abnormality, and especially in endometriosis. However, serum CA-125 concentration is seldom > 100 IU/ml in endometriosis. In this paper, we present a patient with unilateral ovarian endometrioma associated with abnormally high serum CA-125 level (> 6000 U/mL) and after excision of the ovarian tumor, the CA-125 levels returned to normal. Our case further emphasizes the association of high levels of CA-125 with benign gynecologic conditions and we discussed the possible explanations for this abnormal elevation of CA-125 levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651169

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  10 in total

1.  Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.

Authors:  Wei He; Sumith A Kularatne; Kimberly R Kalli; Franklyn G Prendergast; Robert J Amato; George G Klee; Lynn C Hartmann; Philip S Low
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

2.  Ruptured ovarian endometrioma with an extreme rise in serum CA 125 level - A case report: Ovarian endometrioma with very high CA-125 level.

Authors:  Anju Kumari Rani; Deepa Kapoor
Journal:  Gynecol Oncol Case Rep       Date:  2012-05-19

3.  Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis.

Authors:  Mojgan Karimi-Zarchi; Najmeh Dehshiri-Zadeh; Leili Sekhavat; Fahime Nosouhi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-11

4.  Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease.

Authors:  Sung Taek Park; Suk Woo Lee; Min Jeong Kim; Young Mo Kang; Hye Min Moon; Chae Chun Rhim
Journal:  BMC Womens Health       Date:  2017-01-13       Impact factor: 2.809

Review 5.  Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis.

Authors:  Jiacong Wu; Ziyi Fu; Guangquan Liu; Pengfei Xu; Juan Xu; Xuemei Jia
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report.

Authors:  Sepideh Khodaverdi; Soheila Amini-Moghaddam; Fariba Almassi Nokiani; Neda Hashemi; Robabeh Mohammad Beigi
Journal:  Int J Reprod Biomed       Date:  2018-06

7.  Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer.

Authors:  Noor A Lokman; Carmela Ricciardelli; Andrew N Stephens; Thomas W Jobling; Peter Hoffmann; Martin K Oehler
Journal:  Diagnostics (Basel)       Date:  2021-01-04

8.  Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.

Authors:  K S Okunade; O Dawodu; M Adenekan; C M Nwogu; O Awofeso; A O Ugwu; O Salako; S John-Olabode; O F Olowoselu; R I Anorlu
Journal:  Niger J Clin Pract       Date:  2020-08       Impact factor: 0.968

Review 9.  Cancer therapy using tumor-associated antigens to reduce side effects.

Authors:  David Siu
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 5.057

10.  Elevated CA 125 in a CASE of Leaking Endometrioma.

Authors:  Svetha Rao; Supuni Kapurubandara; Anbu Anpalagan
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.